Tivic Health Systems, Inc. (TIVC)
USD 4.73
(-2.85%)
USD 4.73
(-2.85%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.67 Million USD | -24.8% |
| 2022 | 2.22 Million USD | 26.19% |
| 2021 | 1.76 Million USD | -34.86% |
| 2020 | 2.7 Million USD | 314.7% |
| 2019 | 653 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.13 Million USD | -32.32% |
| 2024 Q2 | 591 Thousand USD | -47.84% |
| 2023 Q1 | 1.89 Million USD | -14.82% |
| 2023 Q2 | 1.43 Million USD | -24.31% |
| 2023 Q4 | 1.67 Million USD | 34.78% |
| 2023 Q3 | 1.24 Million USD | -13.45% |
| 2023 FY | 1.67 Million USD | -24.8% |
| 2022 Q1 | 1.6 Million USD | -9.24% |
| 2022 FY | 2.22 Million USD | 26.19% |
| 2022 Q4 | 2.22 Million USD | -8.62% |
| 2022 Q3 | 2.43 Million USD | -14.2% |
| 2022 Q2 | 2.83 Million USD | 77.33% |
| 2021 Q3 | 7.77 Million USD | 26.66% |
| 2021 Q2 | 6.13 Million USD | 66.54% |
| 2021 Q1 | 3.68 Million USD | 36.08% |
| 2021 Q4 | 1.76 Million USD | -77.31% |
| 2021 FY | 1.76 Million USD | -34.86% |
| 2020 Q4 | 2.7 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 2.7 Million USD | 314.7% |
| 2019 FY | 653 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 96.734% |
| BrainsWay Ltd. | 15.31 Million USD | 89.069% |
| Cerus Corporation | 144.3 Million USD | 98.84% |
| Envoy Medical, Inc. | 9.4 Million USD | 82.195% |
| electroCore, Inc. | 8.94 Million USD | 81.286% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 68.663% |
| IceCure Medical Ltd | 4.24 Million USD | 60.584% |
| Inogen, Inc. | 121.38 Million USD | 98.621% |
| OrthoPediatrics Corp. | 72.56 Million USD | 97.693% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 94.341% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 47.391% |
| MaxCyte, Inc. | 36.1 Million USD | 95.364% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | 9.411% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -293.622% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.487% |
| PAVmed Inc | 57.13 Million USD | 97.07% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 93.426% |
| RxSight, Inc. | 22.18 Million USD | 92.455% |
| Sight Sciences, Inc. | 46.43 Million USD | 96.395% |
| SI-BONE, Inc. | 61.05 Million USD | 97.258% |
| TELA Bio, Inc. | 59.16 Million USD | 97.171% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 98.531% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 83.777% |
| Acutus Medical, Inc. | 54.83 Million USD | 96.947% |
| Talis Biomedical Corporation | 29.22 Million USD | 94.272% |
| Spectral AI, Inc. | 12.4 Million USD | 86.501% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 92.764% |
| CVRx, Inc. | 39.28 Million USD | 95.739% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 86.001% |
| PetVivo Holdings, Inc. | 2.42 Million USD | 31.091% |
| Bioventus Inc. | 589.79 Million USD | 99.716% |
| Venus Concept Inc. | 107.1 Million USD | 98.437% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 96.76% |
| LivaNova PLC | 1.15 Billion USD | 99.855% |
| 908 Devices Inc. | 37.49 Million USD | 95.535% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.762% |
| Nemaura Medical Inc. | 26.37 Million USD | 93.654% |
| NeuroPace, Inc. | 86.99 Million USD | 98.076% |
| LENSAR, Inc. | 22.4 Million USD | 92.53% |
| Apyx Medical Corporation | 52.31 Million USD | 96.8% |
| Cutera, Inc. | 518.12 Million USD | 99.677% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 94.292% |
| BioSig Technologies, Inc. | 4.68 Million USD | 64.269% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 97.132% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 92.21% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.924% |
| Axonics, Inc. | 82.35 Million USD | 97.967% |
| Outset Medical, Inc. | 190.91 Million USD | 99.123% |
| IRIDEX Corporation | 24.91 Million USD | 93.281% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.65% |
| IRadimed Corporation | 20.73 Million USD | 91.927% |
| INVO Bioscience, Inc. | 19.99 Million USD | 91.628% |
| Telesis Bio, Inc. | 40.87 Million USD | 95.904% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 95.896% |
| Varex Imaging Corporation | 668.6 Million USD | 99.75% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.772% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 53.135% |
| Pulmonx Corporation | 60.63 Million USD | 97.239% |
| Dynatronics Corporation | 11.78 Million USD | 85.79% |
| Modular Medical, Inc. | 2.27 Million USD | 26.32% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 58.809% |
| Semler Scientific, Inc. | 6.27 Million USD | 73.301% |
| InMode Ltd. | 75.91 Million USD | 97.795% |
| Bruker Corporation | 2.83 Billion USD | 99.941% |
| Cytosorbents Corporation | 29.98 Million USD | 94.417% |
| DexCom, Inc. | 4.19 Billion USD | 99.96% |
| Align Technology, Inc. | 2.45 Billion USD | 99.932% |
| Viveve Medical, Inc. | 10.84 Million USD | 84.567% |
| ZimVie Inc. | 795.85 Million USD | 99.79% |
| Movano Inc. | 5.97 Million USD | 71.969% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 98.4% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -293.622% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 86.001% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.738% |
| Profound Medical Corp. | 12.66 Million USD | 86.783% |
| Insulet Corporation | 1.85 Billion USD | 99.91% |
| enVVeno Medical Corporation | 2.43 Million USD | 31.253% |
| Surmodics, Inc. | 65.82 Million USD | 97.457% |
| iCAD, Inc. | 8 Million USD | 79.078% |
| Nuwellis, Inc. | 6.78 Million USD | 75.31% |
| Biotricity, Inc. | 35.91 Million USD | 95.34% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 99.249% |
| Aethlon Medical, Inc. | 2.47 Million USD | 32.49% |
| InspireMD, Inc. | 8.14 Million USD | 79.44% |
| PAVmed Inc. | 57.13 Million USD | 97.07% |
| BIOLASE, Inc. | 35.34 Million USD | 95.264% |
| Beyond Air, Inc. | 29.77 Million USD | 94.378% |
| FONAR Corporation | 57.45 Million USD | 97.087% |
| AxoGen, Inc. | 101.16 Million USD | 98.345% |
| Vivani Medical, Inc. | 25.03 Million USD | 93.314% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 98.093% |
| Inari Medical, Inc. | 209.32 Million USD | 99.2% |
| UFP Technologies, Inc. | 118.04 Million USD | 98.582% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 86.809% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | 23.415% |
| Tenon Medical, Inc. | 5.56 Million USD | 69.93% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | 5.902% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 90.507% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.947% |
| Sintx Technologies, Inc. | 6.59 Million USD | 74.609% |
| NanoVibronix, Inc. | 2.68 Million USD | 37.677% |
| Quanterix Corporation | 78.08 Million USD | 97.856% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 53.135% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 65.732% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.84% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.706% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 89.965% |
| NeuroMetrix, Inc. | 1.33 Million USD | -25.57% |
| Hyperfine, Inc. | 9.8 Million USD | 82.918% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.331% |
| Biomerica, Inc. | 2.66 Million USD | 37.139% |
| Bone Biologics Corporation | 831.4 Thousand USD | -101.347% |
| AVITA Medical, Inc. | 19.86 Million USD | 91.573% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | 15.184% |
| Silk Road Medical, Inc | 114.15 Million USD | 98.534% |